EMEA-002862-PIP01-20

Key facts

Active substance
COVID-19 vaccine (ChAdOx1-S [recombinant]) (AZD1222)
Therapeutic area
Vaccines
Decision number
P/0003/2021
PIP number
EMEA-002862-PIP01-20
Pharmaceutical form(s)
Concentrate for solution for injection
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
Intramuscular use
Contact for public enquiries
AstraZeneca AB

Tel.  +46 855324400

E-mail: paediatrics@astrazeneca.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings
1 rating
2 ratings
1 rating